Skip to main content
SpringerLink
Log in

Patient Evaluation and OA Study Design: OARSI/Biomarker Qualification

  • HSS Osteoarthritis Symposium: Frontiers in OA
  • Published:
HSS Journal

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Colman, E. G. 2003. The Food and Drug Administration's Osteoporosis Guidance Document: past, present, and future. J Bone Miner Res, 18, 1125–8.

    Article  PubMed  Google Scholar 

  2. Conaghan, P. G., Hunter, D. J., Maillefert, J. F., Reichmann, W. M. & Losina, E. 2011. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis Cartilage, 19, 606–10.

    Article  PubMed  CAS  Google Scholar 

  3. FDA, F. A. D. A. 2010. Guidance for Industry: Qualification Process for Drug Development Tools. October.

  4. Kraus, V. B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., Heinegard, D., Ko, A., Lohmander, S., Matthews, G., Menetski, J., Moskowitz, R., Persiani, S., Poole, R., Rousseau, J. C. & Todman, M. 2011. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage.

  5. Wagner, J. A., Williams, S. A. & Webster, C. J. 2007. Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther, 81, 104–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The author wishes to acknowledge NIH NIAMS PO1 AR050245, NIA Claude D. Pepper Older Americans Independence Centers 5P30 AG028716, and NIA R21 AG039782-01 for funding support.

Disclosures

The author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.

Author information

Authors and Affiliations

  1. Duke University Medical Center, Box 3416, Durham, NC, 27710, USA

    Virginia Byers Kraus MD, PhD

Authors
  1. Virginia Byers Kraus MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Virginia Byers Kraus MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kraus, V.B. Patient Evaluation and OA Study Design: OARSI/Biomarker Qualification. HSS Jrnl 8, 64–65 (2012). https://doi.org/10.1007/s11420-011-9234-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11420-011-9234-z

Keyword

Search

Navigation